Financhill
Back

Sangamo Therapeutics Quote, Financials, Valuation and Earnings

Sangamo Therapeutics Price Quote

$2.48
0.00 (7.36%)
(Updated: December 21, 2024 at 5:46 AM ET)

Sangamo Therapeutics Key Stats

Buy
57
Sangamo Therapeutics (SGMO) is a Buy

Day range:
$2.25 - $2.53
52-week range:
$0.30 - $3.18
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.22
P/B ratio:
13.25%

Volume:
13.6M
Avg. volume:
7.6M
1-year change:
585.71%
Market cap:
$518.5M
Revenue:
$176.2M
EPS:
$-0.75

How Much Does Sangamo Therapeutics Make?

Data Unavailable

Is Sangamo Therapeutics Growing As A Company?

Data Unavailable

Sangamo Therapeutics Stock Price Performance

What Is Sangamo Therapeutics 52-Week High & Low?

Sangamo Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sangamo Therapeutics?

Data Unavailable

Is Sangamo Therapeutics Cash Flow Positive?

Data Unavailable

Sangamo Therapeutics Return On Invested Capital

Data Unavailable

Sangamo Therapeutics Earnings Date & Stock Price

Sangamo Therapeutics Competitors

  • Who Are Sangamo Therapeutics's Competitors?
    Below is a list of companies who compete with Sangamo Therapeutics or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Pfizer Inc (PFE)
    • Protalix BioTherapeutics Inc (PLX)

Sangamo Therapeutics Dividend Yield

Data Unavailable

Sangamo Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -9.4%
Revenue: 425.77% 97.09%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 6.33
Upside from Last Price: 154.86%

Major Shareholders

Data Unavailable